Zheng Zhou

Prof. Dr. Zheng Zhou

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2006 in Journal of Experimental Medicine
Verified
Journal Article
Open access
ZZZheng Zhou
Zheng Zhou
DIDavid Immel
David Immel
CXCai-Xia Xi
Cai-Xia Xi
ABAngelika Bierhaus
Angelika Bierhaus
XFXu Feng
Xu Feng
WXWen-Cheng Xiong
Wen-Cheng Xiong
The receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin superfamily that has multiple ligands and is implicated in the pathogenesis of various diseases, including diabetic complications, neurodegenerative disorders, and inflammatory responses. However, the role of RAGE in normal physiology is largely undefined. Here, we present evidence for a role of RAGE in osteoclast maturation and function, which has consequences for bone remodeling. Mice lacking RAGE had increased bone mass and bone mineral density and decreased bone resorptive activity in vivo. In vitro–differentiated RAGE-deficient osteoclasts exhibited disrupted actin ring and sealing zone structures, impaired maturation, and reduced bone resorptive activity. Impaired signaling downstream of αvβ3 integrin was observed in RAGE−/− bone marrow macrophages and precursors of OCs. These results demonstrate a role for RAGE in osteoclast actin cytoskeletal reorganization, adhesion, and function, and suggest that the osteosclerotic-like phenotype observed in RAGE knockout mice is due to a defect in osteoclast function.

1 July 2008 in Journal of Bone and Mineral Research
Verified
Journal Article
Closed access
PDF file
ZZZheng Zhou
Zheng Zhou
JHJun-Yan Han
Jun-Yan Han
CXCai-Xia Xi
Cai-Xia Xi
JXJian-Xin Xie
Jian-Xin Xie
XFXu Feng
Xu Feng
WXWen-Cheng Xiong
Wen-Cheng Xiong
High-mobility group box 1 (HMGB1), a nonhistone nuclear protein, is released by macrophages into the extracellular milieu consequent to cellular activation. Extracellular HMGB1 has properties of a pro-inflammatory cytokine through its interaction with receptor for advanced glycation endproducts (RAGE) and/or toll-like receptors (TLR2 and TLR4). Although HMGB1 is highly expressed in macrophages and differentiating osteoclasts, its role in osteoclastogenesis remains largely unknown. In this report, we present evidence for a function of HMGB1 in this event. HMGB1 is released from macrophages in response to RANKL stimulation and is required for RANKL-induced osteoclastogenesis in vitro and in vivo. In addition, HMGB1, like other osteoclastogenic cytokines (e.g., TNFα), enhances RANKL-induced osteoclastogenesis in vivo and in vitro at subthreshold concentrations of RANKL, which alone would be insufficient. The role of HMGB1 in osteoclastogenesis is mediated, in large part, by its interaction with RAGE, an immunoglobin domain containing family receptor that plays an important role in osteoclast terminal differentiation and activation. HMGB1-RAGE signaling seems to be important in regulating actin cytoskeleton reorganization, thereby participating in RANKL-induced and integrin-dependent osteoclastogenesis. Taken together, these observations show a novel function of HMGB1 in osteoclastogenesis and provide a new link between inflammatory mechanisms and bone resorption.

1 July 2010 in Developmental Cell
Verified
Journal Article
Closed access
ZZZheng Zhou
Zheng Zhou
JXJianxin Xie
Jianxin Xie
DLDaehoon Lee
Daehoon Lee
YLYu Liu
Yu Liu
JJJiung Jung
Jiung Jung
WXWen-Cheng Xiong
Wen-Cheng Xiong

1 October 2008 in Neuron
Verified
Journal Article
Closed access
SLShiwen Luo
Shiwen Luo
BZBin Zhang
Bin Zhang
Xianping DongXianping Dong
Xianping Dong
YTYanmei Tao
Yanmei Tao
ATAnnie Ting
Annie Ting
LMLin Mei
Lin Mei

28 August 2019 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
CLChunyan Liu
Chunyan Liu
XQXia Qi
Xia Qi
JAJamal Alhabeil
Jamal Alhabeil
HLHaiyan Lu
Haiyan Lu
ZZZheng Zhou
Zheng Zhou

2 December 2009 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
CXCai-Xia Xi
Cai-Xia Xi
FXFei Xiong
Fei Xiong
ZZZheng Zhou
Zheng Zhou
LMLin Mei
Lin Mei
WXWen-Cheng Xiong
Wen-Cheng Xiong
PYK2 regulates inflammation by modulating MyD88 signaling. PYK2, a major cell adhesion-activated tyrosine kinase, is highly expressed in macrophages and implicated in macrophage activation and inflammatory response. However, mechanisms by which PYK2 regulates inflammatory response are beginning to be understood. In this study, we demonstrate that PYK2 interacts with MyD88, a crucial signaling adaptor protein in LPS and PGN-induced NF-κB activation, in vitro and in macrophages. This interaction, increased in macrophages, stimulated by LPS, requires the death domain of MyD88. PYK2-deficient macrophages exhibit reduced phosphorylation and degradation of IκB, an inhibitor of NF-κB nuclear translocation, and decreased NF-κB activation and IL-1β expression by LPS. These results suggest that via interaction with MyD88, PYK2 is involved in modulating cytokine (e.g., LPS) stimulation of NF-κB activity and signaling, providing a mechanism underlying PYK2 regulation of an inflammatory response.